Innovation
Technology & innovation
Tience technology
Tience® is the first-of-its-kind regenerative technology that improves skin functionality by harnessing the reparative potential of human fat tissue in a ready-to-use product. It naturally stimulates the skin’s healing and renewal processes using only bioregenerative substances, delivering long-lasting results for improved skin condition, structure, and elasticity.
It is the first ready-to-use product of human origin designed for medical aesthetic applications. It has been classified as a tissue product under European Cell and Tissue Directive (EUTCD).
Offering results comparable to traditional autologous methods but without the complexity, Tience® provides healthcare professionals with an efficient, sustainable, and clinically validated treatment. Ideal for treating aging skin, wrinkles, scars, and hard-to-treat areas like the under-eye and perioral skin, Tience® offers natural, sustainable solutions for enhanced skin health and appearance.
Leveraging Tience technology
Linio Biotech is first and foremost a research and development company. Our R&D is focused on leveraging Tience technology in variety of future medical devices that address unmet needs in skin regeneration and soft tissue restoration.
With a dedicated team of in-house scientists, state-of-the-art research laboratories, and trusted collaborations with external CDMO partners, we ensure a seamless integration of science, technology, and manufacturing expertise. Together, we are driving innovation to deliver safe, effective, and accessible solutions for patients worldwide.
Unique patented technology
Tience technology and it’s production process are covered by international patents.
Unique patented technology
Tience technology and it’s production process are covered by international patents.
Looking to invest in the future of regenerative skin treatments?
Advancing Regenerative Medicine
At Linio Biotech, we are committed to quality research and further leveraging Tience® technology in innovative, natural, and long-lasting solutions for soft-tissue deficiencies and defects. Our pioneering technology in functional tissue regeneration positions us at the forefront of the regenerative aesthetic industry, with a clear strategic focus on transformative and research proven outcomes.
Our Vision
To become a global leader in regenerative aesthetics by providing ready-to-use products that deliver the benefits of autologous methods without the associated complexity and cost.
Tience® technology fills a critical gap in the aesthetics and regenerative medicine landscape by offering a bioregenerative solution that overcomes the limitations of traditional treatments:
- Long-Lasting, Natural Results: Unlike synthetic products that require frequent maintenance, Tience® promotes natural tissue regeneration for natural, durable, aesthetically pleasing outcomes.
- Enhanced Tissue Integration: Designed to support the tissue’s natural healing processes, Tience® ensures superior biocompatibility, reducing the likelihood of adverse reactions common with synthetic materials.
- Personalized, Adaptive Treatment: Tience® adapts to individual patient biology, offering tailored regenerative solutions that go beyond the limitations of one-size-fits-all products.
- Expanding Treatment Possibilities: For patients with significant soft-tissue deficiencies or cases where traditional treatments fall short, Tience® opens new therapeutic possibilities.
Why Invest in Linio Biotech?
Why Invest in Linio Biotech?
Innovative Technology
Proven bioregeneration technology with scientific and validation, on-going research.
Market Potential
Targeting high-growth aesthetic markets in the EU and USA.
Strategic Focus
Clear path towards EU and FDA approval and commercial partnerships.
investments, inquiries & Partnerships